Literature DB >> 23891959

Recurrence of non-invasive intraductal papillary municious neoplasm seven years following total pancreatectomy.

Nayima M Clermont Dejean1, Sinziana Dumitra, Jeffrey S Barkun.   

Abstract

INTRODUCTION: Intraductal papillary mucinous neoplasm is an increasingly recognized disease with varying premalignant potential and unclear incidence, characterized by a mucin-producing epithelium and dilation of the pancreatic duct. PRESENTATION OF CASE: We present the first documented case of distant intestinal intraductal papillary mucinous neoplasm recurrence following total pancreatectomy for side-branch non-invasive borderline malignant intraductal papillary mucinous neoplasm. DISCUSSION: We review the current literature in order to try and answer important questions regarding our ability to predict intraductal papillary mucinous neoplasm recurrence, our understanding of the potential for recurrence and what follow-up should be recommended to properly monitor recurrence after a benign, albeit borderline malignant, side-branch lesion resection.
CONCLUSION: Our case report confirms that the low risk classification of an intraductal papillary mucinous neoplasm lesion even after total pancreatectomy does not always predict recurrence and that definitive prognostic factors of recurrence in the setting of non-invasive disease have yet to be identified. A vigilant long-term approach to follow-up may thus be required even in low risk cases.
Copyright © 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EUS; IPMN; MRCP; Management; Neoplasm; Pancreas; Pancreatectomy; Recurrence; endoscopic ultrasound; intraductal papillary mucinous neoplasm; magnetic resonance cholangiopancreatography

Year:  2013        PMID: 23891959      PMCID: PMC3741449          DOI: 10.1016/j.ijscr.2013.05.009

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  25 in total

1.  Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.

Authors:  Guillaume Passot; Roger Lebeau; Valérie Hervieu; Thierry Ponchon; Franck Pilleul; Mustapha Adham
Journal:  Pancreas       Date:  2012-01       Impact factor: 3.327

Review 2.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

3.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Sun Youn Bae; Kyu Taek Lee; Jin Hee Lee; Jong Kyun Lee; Kwang Hyuck Lee; Jong Chul Rhee
Journal:  Dig Liver Dis       Date:  2011-10-24       Impact factor: 4.088

5.  Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Roberto Salvia; Stefano Crippa; Stefano Partelli; Giulia Armatura; Giuseppe Malleo; Marina Paini; Antonio Pea; Claudio Bassi
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 6.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

7.  Multifocal branch-duct pancreatic intraductal papillary mucinous neoplasms.

Authors:  Yoshitsugu Tajima; Tamotsu Kuroki; Noritsugu Tsuneoka; Amane Kitasato; Tomohiko Adachi; Takehiro Mishima; Taiichiro Kosaka; Takashi Kanematsu
Journal:  Am J Surg       Date:  2008-05-29       Impact factor: 2.565

8.  18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Cosimo Sperti; Sergio Bissoli; Claudio Pasquali; Laura Frison; Guido Liessi; Franca Chierichetti; Sergio Pedrazzoli
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

9.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  1 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.